Três Tentos Agroindustrial S/A (TTEN3.SA)
BRL 13.98
(-4.83%)
BRL 13.98
(-4.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 727.61 Million | 257.69 Million | 105.52 Million | 79.97 Million | 19.82 Million | 97.49 Million |
| Net Income | 575.28 Million | 540.32 Million | 379.83 Million | 255.44 Million | 120.81 Million | 125.22 Million |
| Depreciation & Amortization | 57.59 Million | 37.74 Million | 27.46 Million | 19.6 Million | 15.21 Million | 11.97 Million |
| Deferred income taxes | 252.82 Million | -35.88 Million | -15.98 Million | - | - | - |
| Stock-based compensation | 9.18 Million | 11.77 Million | 13.31 Million | - | - | - |
| Change in working capital | 388 Million | -337.2 Million | -494.12 Million | -281.25 Million | -140.52 Million | -61.58 Million |
| Other non-cash items | -555.28 Million | 40.93 Million | 195.02 Million | 86.18 Million | 230.01 Million | 87.95 Million |
| Investing Cash Flow | -459.79 Million | -39.94 Million | -1.12 Billion | -73.99 Million | -59.2 Million | -12.56 Million |
| Investments in PPE | -493.72 Million | -716.13 Million | -384.53 Million | -77.58 Million | -59.2 Million | -12.56 Million |
| Acquisitions | -13.02 Million | - | - | 3.59 Million | - | - |
| Investment purchases | 474.93 Million | - | -739 Million | - | - | - |
| Sales/Maturities of investments | 46.94 Million | 676.19 Million | - | - | - | - |
| Other Investing Activities | -474.93 Million | -716.07 Million | -739 Million | -55 Thousand | -189 Thousand | -104 Thousand |
| Financing Cash Flow | 36.35 Million | 154.97 Million | 1.11 Billion | 82.74 Million | 72.02 Million | 10.52 Million |
| Debt repayment | -95.44 Million | -766.02 Million | -810.26 Million | -347.81 Million | -95.21 Million | -20.16 Million |
| Dividends payments | -57.23 Million | -7.59 Million | -25.72 Million | -28.25 Million | -20.45 Million | -9.63 Million |
| Common Stock Repurchased | -1.47 Million | - | - | - | - | - |
| Common Stock Issuance | 7.21 Million | 11.33 Million | 1.15 Billion | - | - | - |
| Other Financing Activities | 183.29 Million | 917.26 Million | 799.96 Million | 458.8 Million | -2.73 Million | - |
| Accounts receivables | -275.61 Million | -423.29 Million | -215.92 Million | -75.36 Million | -181.27 Million | -109.4 Million |
| Accounts payables | 152.21 Million | 626.13 Million | -155.34 Million | 74.91 Million | 198.5 Million | 26.61 Million |
| Inventory | 500.6 Million | -562.07 Million | -135.49 Million | -104.17 Million | -192.49 Million | 40.66 Million |
| Other working capital | 10.8 Million | 22.03 Million | 12.64 Million | -176.62 Million | 34.73 Million | -19.44 Million |
| Cash at beginning of period | 724.31 Million | 351.59 Million | 252.69 Million | 163.97 Million | 131.32 Million | 35.87 Million |
| Cash at end of period | 1.02 Billion | 724.31 Million | 351.59 Million | 252.69 Million | 163.97 Million | 131.32 Million |
| Capital Expenditure | -493.72 Million | -716.13 Million | -384.53 Million | -77.58 Million | -59.2 Million | -12.56 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 304.16 Million | 372.72 Million | 98.89 Million | 88.72 Million | 32.64 Million | 95.45 Million |
| Free Cash Flow | 233.89 Million | -458.44 Million | -279.01 Million | 2.39 Million | -39.38 Million | 84.93 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 146.27 Million | 157.42 Million | 173.21 Million | 575.28 Million | 115.31 Million | 57.97 Million |
| Depreciation & Amortization | 21.91 Million | 22.86 Million | 17.14 Million | 57.59 Million | 15.96 Million | 12.66 Million |
| Deferred income taxes | - | - | -8.6 Million | 252.82 Million | -33.79 Million | -37.34 Million |
| Stock-based compensation | 1.4 Million | 1.62 Million | 2.39 Million | 9.18 Million | 2.55 Million | 2.24 Million |
| Change in working capital | 26.12 Million | -226.65 Million | -41.9 Million | 388 Million | 552.46 Million | -242.75 Million |
| Other non-cash items | 1.11 Million | 273.33 Million | -65.87 Million | -555.28 Million | -10.74 Million | 16.56 Million |
| Investing Cash Flow | -149.78 Million | -73.2 Million | -53.48 Million | -459.79 Million | -158.62 Million | -132.08 Million |
| Investments in PPE | -125.75 Million | -143.57 Million | -105.51 Million | -493.72 Million | -112.76 Million | -144.59 Million |
| Acquisitions | - | -42.99 Million | - | -13.02 Million | -13.02 Million | - |
| Investment purchases | -5.25 Million | - | 5.08 Million | 474.93 Million | -5.08 Million | - |
| Sales/Maturities of investments | -18.78 Million | 70.37 Million | 46.94 Million | 46.94 Million | -27.75 Million | 12.5 Million |
| Other Investing Activities | 125.96 Million | -131.21 Million | 48.22 Million | -474.93 Million | -41.24 Million | 9.99 Million |
| Financing Cash Flow | 517.7 Million | 59.92 Million | 91.16 Million | 36.35 Million | -215.64 Million | 37.77 Million |
| Debt repayment | -508.32 Million | -132.68 Million | -92.7 Million | -95.44 Million | -258.83 Million | -181.53 Million |
| Dividends payments | -727 Thousand | -58.41 Million | - | -57.23 Million | - | - |
| Common Stock Repurchased | 8 Million | -14.05 Million | -525 Thousand | -1.47 Million | - | -949 Thousand |
| Common Stock Issuance | 1.8 Million | 1.35 Million | 451 Thousand | 7.21 Million | 902 Thousand | 902 Thousand |
| Other Financing Activities | -426 Thousand | -57.05 Million | 369.34 Million | 183.29 Million | 42.29 Million | 220.29 Million |
| Accounts receivables | 843.11 Million | -344.04 Million | -715 Million | -275.61 Million | -43.99 Million | 488.49 Million |
| Accounts payables | -376.08 Million | 74.31 Million | 245.43 Million | 152.21 Million | 400.79 Million | -693.26 Million |
| Inventory | -473.08 Million | 8.54 Million | 497.65 Million | 500.6 Million | 142.47 Million | -74.49 Million |
| Other working capital | 32.17 Million | 34.54 Million | -69.97 Million | 10.8 Million | 53.19 Million | 36.5 Million |
| Cash at beginning of period | 935.23 Million | 1.02 Billion | 914.43 Million | 724.31 Million | 646.95 Million | 931.91 Million |
| Cash at end of period | 1.44 Billion | 935.23 Million | 1.02 Billion | 1.02 Billion | 914.43 Million | 646.95 Million |
| Capital Expenditure | -125.75 Million | -143.57 Million | -105.51 Million | -493.72 Million | -112.76 Million | -144.59 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 513.46 Million | -93.24 Million | 114.04 Million | 304.16 Million | 267.48 Million | -284.96 Million |
| Free Cash Flow | 19.79 Million | -223.54 Million | -29.14 Million | 233.89 Million | 528.99 Million | -335.24 Million |
0440
BOD
RESONANCE
DNFGF
ASHIMASYN
GGRP